Stage 1
3,303
Listed
Starting count
Every peptide offered by every vendor in the public catalog.
Public COA index
Search 6,435 public COAs linked to visible peptide listings. Browse by peptide, vendor, lab, lot, test date, or reported purity.
A record means we matched a stored COA to a listed product. It does not grade product quality. How to read a COA · New to peptides? Start with the beginner’s guide
Coverage
Stage 1
3,303
Listed
Starting count
Every peptide offered by every vendor in the public catalog.
Stage 2
2,889
In stock
87.5% remain
Listed products currently marked in stock.
Stage 3
1,620
With a COA
56.1% remain
In-stock products matched to a COA in this index.
Stage 4
1,323
Tested in past year
81.7% remain
Those COAs with a printed test date in the past 12 months.
Missing COAs count as gaps. COAs without a printed test date do not count as recent.
Current listings matched to indexed COAs and recorded prices.
Data current as of Sep 28, 2026
6,435
Documents in scope
Stored COAs tied to visible, non-wholesale market pairs.
1,788
Current pairs
Newest eligible document for 54.1% of tracked vendor–peptide pairs.
85 / 111
Peptides covered
Catalog peptides with at least one current certificate on file.
78 / 96
Vendors covered
Visible vendors with at least one current certificate on file.
Recent changes
These are the newest eligible certificate updates in the index. A vendor may have testing that we have not indexed.
| Peptide | Vendor | Laboratory named | Test date | Reported purity | Record |
|---|---|---|---|---|---|
| MK-677 | Disguised Alpha | Chromate | Sep 19, 2026 | No purity printed | View COA |
| Livagen | Pure Lab Peptides | Chromatec | Sep 19, 2026 | 98.485% | View COA |
| Vilon | Pure Lab Peptides | Chromate | Sep 19, 2026 | 99.064% | View COA |
| Cardiogen | Pure Lab Peptides | Chromatide | Sep 19, 2026 | 99.768% | View COA |
| GHK-Cu | Chameleon Peptides | Vanguard Laboratory | Sep 18, 2026 | No purity printed | View COA |
| Thymalin | Disguised Alpha | ILS Laboratories | Sep 18, 2026 | 99.03% | View COA |
| Retatrutide | Peptide Partners | Chromate | Sep 17, 2026 | No purity printed | View COA |
| Vesugen | Pure Lab Peptides | Chromate | Sep 17, 2026 | 99.892% | View COA |
| Testagen | Pure Lab Peptides | Chromatac | Sep 17, 2026 | 98.484% | View COA |
| Melanotan II | Panda Peptides | ILS Laboratories | Sep 16, 2026 | 99.62% | View COA |
| PT-141 | Panda Peptides | ILS Laboratories | Sep 16, 2026 | 99.83% | View COA |
| Ipamorelin | Panda Peptides | ILS Laboratories | Sep 16, 2026 | 99.82% | View COA |
Peptide, laboratory, date, lot, and purity fields are transcribed from the certificate. “On file” describes our records and carries no product-quality or safety rating.
Coverage by molecule
Open a peptide to see its current COA table alongside vendor pricing. The totals measure document coverage and do not rank vendors or peptides.
Peptide testing labs
These are laboratory names printed on certificates in the current index. Open a lab to see the peptides, vendors, dates, lots, and reported purity fields tied to those records. Counts describe our coverage; they do not rank or endorse labs.
Data quality
We publish a narrower set of records than we collect.
Only stored documents classified as COAs and matched to a catalog peptide are eligible. The public view also requires a visible, non-wholesale vendor–peptide market pair.
We show the newest eligible certificate for each vendor–peptide pair. We set aside future-dated records so they cannot replace a valid current record.
Records more than 18 calendar months old are labeled as older. Test date, lab, lot, compound, and purity are transcribed fields and may be absent.
Printed laboratory text remains visible. We group obvious name variants only for counting. An uncovered listing may still have testing that is not in our index.
Among current records, 96.9% include a test date, 99.1% name a laboratory, and 85.2% report a purity value. Test dates in the current index run from July 2021 through September 2026.
For structured extraction, use the plain-text COA dataset summary.